It should document a BMI of 30 or higher (or 27-plus with a comorbidity like hypertension, type 2 diabetes, dyslipidemia, or sleep apnea), failed diet and exercise, and cardiovascular or metabolic risk
GLP-1 Receptor Agonists: Are They a Cure for Everything
[ref open access] Why could the risk be greater during infancy
For this reason, tirzepatide has shown promising results in clinical trials for chronic weight management
What research has explored: Published studies in journals including Metabolism and the Journal of Ethnopharmacology have examined berberine in the context of glucose metabolism, insulin sensitivity, and metabolic signaling pathways
And these are not just anecdotal